A Simple Food-Diverting Operation for Type 2 Diabetes Treatment. Preliminary Results in Humans with BMI 28–32 kg/m2

[1]  R. Seeley,et al.  A novel approach to glycemic control in type 2 diabetes mellitus, partial jejunal diversion: pre-clinical to clinical pathway , 2017, BMJ Open Diabetes Research & Care.

[2]  Jia-qing Cao,et al.  Small Intestinal Bypass Induces a Persistent Weight-Loss Effect and Improves Glucose Tolerance in Obese Rats , 2017, Obesity Surgery.

[3]  J. Papadakis,et al.  Is a Simple Food-Diverting Operation the Solution for Type 2 Diabetes Treatment? Experimental Study in a Non-Obese Rat Model , 2016, Obesity Surgery.

[4]  Wei-Jei Lee,et al.  The Effect and Predictive Score of Gastric Bypass and Sleeve Gastrectomy on Type 2 Diabetes Mellitus Patients with BMI < 30 kg/m2 , 2015, Obesity Surgery.

[5]  Deepak L. Bhatt,et al.  Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes. , 2014, The New England journal of medicine.

[6]  K. Perisinakis,et al.  Alterations of Global Gastrointestinal Motility After Sleeve Gastrectomy: A Prospective Study , 2013, Annals of surgery.

[7]  J. Papadakis,et al.  Alterations in Gut Hormones After Laparoscopic Sleeve Gastrectomy: A Prospective Clinical and Laboratory Investigational Study , 2013, Annals of surgery.

[8]  Sanyuan Hu,et al.  Type 2 Diabetes Control in a Nonobese Rat Model Using Sleeve Gastrectomy with Duodenal–Jejunal Bypass (SGDJB) , 2012, Obesity Surgery.

[9]  M. Santo,et al.  Sleeve Gastrectomy With Transit Bipartition: A Potent Intervention for Metabolic Syndrome and Obesity , 2012, Annals of surgery.

[10]  J. Grammatikakis,et al.  Sleeve Gastrectomy Plus Side-to-Side Jejunoileal Anastomosis for the Treatment of Morbid Obesity and Metabolic Diseases: a Promising Operation , 2012, Obesity Surgery.

[11]  S. Bloom,et al.  Gut Hormones and Appetite Control: A Focus on PYY and GLP-1 as Therapeutic Targets in Obesity , 2012, Gut and liver.

[12]  S. Woods,et al.  Weight-independent changes in blood glucose homeostasis after gastric bypass or vertical sleeve gastrectomy in rats. , 2011, Gastroenterology.

[13]  E. Ferrannini,et al.  Improvement in Insulin Sensitivity and Β-Cell Function Following Ileal Interposition with Sleeve Gastrectomy in Type 2 Diabetic Patients: Potential Mechanisms , 2011, Journal of Gastrointestinal Surgery.

[14]  J. Campos,et al.  Gastric Bypass in the Treatment of Type 2 Diabetes in Patients with a BMI of 30 to 35 kg/m2 , 2011, Obesity surgery.

[15]  N. Scopinaro,et al.  Metabolic Surgery for the Treatment of Type 2 Diabetes in Patients with BMI <35 kg/m2: An Integrative Review of Early Studies , 2010, Obesity surgery.

[16]  F. Rubino,et al.  The Diabetes Surgery Summit Consensus Conference: Recommendations for the Evaluation and Use of Gastrointestinal Surgery to Treat Type 2 Diabetes Mellitus , 2010, Annals of surgery.

[17]  B. Ludvik,et al.  Sleeve Gastrectomy as Sole and Definitive Bariatric Procedure: 5-Year Results for Weight Loss and Ghrelin , 2010, Obesity surgery.

[18]  C. Beglinger,et al.  Improvement in Glucose Metabolism After Bariatric Surgery: Comparison of Laparoscopic Roux-en-Y Gastric Bypass and Laparoscopic Sleeve Gastrectomy: A Prospective Randomized Trial , 2009, Annals of surgery.

[19]  M. Jensen,et al.  Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. , 2009, The American journal of medicine.

[20]  D. Zheng,et al.  Mechanism for improved insulin sensitivity after gastric bypass surgery. , 2008, The Journal of clinical endocrinology and metabolism.

[21]  G. Mingrone.  Role of the incretin system in the remission of type 2 diabetes following bariatric surgery. , 2008, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[22]  J. Papadakis,et al.  Sleeve Gastrectomy—A “Food Limiting” Operation , 2008, Obesity surgery.

[23]  J. Lau,et al.  Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis. , 2007, JAMA.

[24]  N. Scopinaro,et al.  Long-Term Control of Type 2 Diabetes Mellitus and the Other Major Components of the Metabolic Syndrome after Biliopancreatic Diversion in Patients with BMI <35 kg/m2 , 2007, Obesity surgery.

[25]  F. Rubino,et al.  Duodenal-jejunal bypass for the treatment of type 2 diabetes in patients with body mass index of 22-34 kg/m2: a report of 2 cases. , 2007, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[26]  J. Marescaux,et al.  The Mechanism of Diabetes Control After Gastrointestinal Bypass Surgery Reveals a Role of the Proximal Small Intestine in the Pathophysiology of Type 2 Diabetes , 2006, Annals of surgery.

[27]  H. Haro,et al.  Report of 2 cases , 2008 .

[28]  D. Rakheja,et al.  A Report of 2 Cases , 2002 .